Viewing data from:

NALTREXONE HYDROCHLORIDE

ANDA

NALTREXONE HYDROCHLORIDE | A075274 | ELITE LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 6 NDCs

Highest NADAC/Unit

$1.19

per ea

Lowest NADAC/Unit

$1.19

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64850030001NALTREXONE 50 MG TABLET	$1.19	EA	Generic	—	2026-06-17
64850030030NALTREXONE 50 MG TABLET	$1.19	EA	Generic	—	2026-06-17
68094085361NALTREXONE 50 MG TABLET	$1.19	EA	Generic	—	2026-06-17
68094085366NALTREXONE 50 MG TABLET	$1.19	EA	Generic	—	2026-06-17
68094090930NALTREXONE 50 MG TABLET	$1.19	EA	Generic	—	2026-06-17
68094090950NALTREXONE 50 MG TABLET	$1.19	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 7 NDCs (7 FSS)

Lowest Price

$21.18

Highest Price

$315.56

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
64850-0300-01NALTREXONE (EQV-REVIA) 50MG TAB	$85.01	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
64850-0300-30NALTREXONE (EQV-REVIA) 50MG TAB	$29.75	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
68094-0853-61NALTREXONE (EQV-REVIA) 50MG TAB	$315.56	FSS	Golden State Medical Supply, Inc.	06/14/2028
68094-0853-62NALTREXONE (EQV-REVIA) 50MG TAB	$66.99	FSS	Golden State Medical Supply, Inc.	06/14/2028
68094-0853-66NALTREXONE (EQV-REVIA) 50MG TAB	$64.19	FSS	Golden State Medical Supply, Inc.	06/14/2028
72162-2311-03NALTREXONE (EQV-REVIA) 50MG TAB	$95.98	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
42291-0632-30NALTREXONE (EQV-REVIA) 50MG TAB	$21.18	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain9 active DMFs

8 active API suppliers hold Drug Master Files for this ingredient.

ASPEN OSS BVNALTREXONE HYDROCHLORIDE

DMF 151022000

FRANCOPIA A EUROAPI CONALTREXONE HYDROCHLORIDE

DMF 206232007

SUN PHARMACEUTICAL INDUSTRIES LTDNALTREXONE HYDROCHLORIDE USP (DIHYDRATE FORM)

DMF 212172007

MACFARLAN SMITH LTDNALTREXONE HYDROCHLORIDE

DMF 215902008

SIEGFRIED LTDNALTREXONE HYDROCHLORIDE

DMF 232142009

NORAMCO LLCNALTREXONE HYDROCHLORIDE DRUG SUBSTANCE

DMF 233252009

SUN PHARMACEUTICAL INDUSTRIES LTDNALTREXONE HYDROCHLORIDE USP (DIHYDRATE FORM) (PROCESS-II)

DMF 365602022

SANECA PHARMACEUTICALS ASNALTREXONE HYDROCHLORIDE

DMF 412642025

STHREE CHEMICALS PRIVATE LTDNALTREXONE HYDROCHLORIDE USP

DMF 424342025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
May 26, 1999	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 50MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 26, 1999

No patent or exclusivity listings for this strength.